EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Targeting de novo lipogenesis to mitigate kidney disease

Haikuo Li, Benjamin D Humphreys

Journal of Clinical Investigation · 15.02.2024 · 134 (4)

DOI: 10.1172/jci178125 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.02.2024. Verfasst von Haikuo Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, and. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ten percent of the population worldwide suffers from chronic kidney disease (CKD), but the mechanisms driving CKD pathology are incompletely understood. While dysregulated lipid metabolism is one hallmark of CKD, the pathogenesis of cellular lipid accumulation remains unclear. In this issue of the JCI, Mukhi et al. Identify acyl-CoA synthetase short-chain family 2 (ACSS2) as a disease risk gene and demonstrate a role for ACSS2 in de novo lipogenesis (DNL). Notably, genetic or pharmacological inhibition of DNL protected against kidney disease progression in mice. These findings warrant evaluation of DNL inhibition with respect to efficacy and safety in people with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicNon-alcoholic Fatty Liver DiseaseHumansAnimalsMiceLipogenesisLiver

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, and.
  • Department of Developmental Biology, Washington University in St. Louis, St. Louis, Missouri, USA.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Li, H., & Humphreys, B. D. (2024). Targeting de novo lipogenesis to mitigate kidney disease. Journal of Clinical Investigation, 134(4). https://doi.org/10.1172/jci178125

Vancouver

Li H, Humphreys BD. Targeting de novo lipogenesis to mitigate kidney disease. Journal of Clinical Investigation. 2024;134(4). doi:10.1172/jci178125

BibTeX
@article{Li2024,
  author = {Li, Haikuo and Humphreys, Benjamin D},
  title = {Targeting de novo lipogenesis to mitigate kidney disease},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {4},
  doi = {10.1172/jci178125}
}
Kostenlos starten →